Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Medline Inc.
MDLN
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $35.3B
$43.06
▲ +3.19%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$32.82 - $50.88
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 1.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Vertically integrated manufacturing and distribution capabilities
- Diversified product portfolio across multiple healthcare settings
- Established relationships with hospitals and post-acute care facilities
- Supply chain optimization expertise and logistics infrastructure
Bear Case
2 risks
- Low volatility (beta -0.4).
- Premium valuation to sector peers
Growth
Moderate growth ahead
Aging global population increasing healthcare utilization
Value
Premium valuation to sector peers
Momentum
Weak
-5.8% over 3m
Quality
Stable
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying MDLN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 5, 2026
MAY 6, 2026
Reported EPS of $0.33 vs $0.30 consensus (+11.8% surprise). Revenue of $7.4B vs $7.2B expected (+2.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+11.8%
Next: Aug 5, 2026
Revenue trend · last 7Q
—
—
—
+11%
+11%
+22%
+11%
Q2 24
Q3 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$6.2B
$6.4B
$6.6B
$6.9B
$7.1B
$7.8B
$7.4B
Margins · last 7Q
Gross
22.6%
Operating
5.7%
Profit
1.8%
Wall Street consensus
13 analysts · 85% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
85%
Hold
15%
Sell
0%
Median Price Target
$43.50
▲ +1.0% vs $43.06
Latest: William Blair · Jun 4, 2026
2 analysts covering
vs Industry
How MDLN stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.